• 1
    Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999; 45(Suppl. 2): II437.
  • 2
    Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001; 120: 65268.
  • 3
    Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994; 107: 27193.
  • 4
    Cervero F, Laird JM. Visceral pain. Lancet 1999; 353: 21458.
  • 5
    Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1973; 14: 12532.
  • 6
    Mertz H, Naliboff B, Munakata J, et al. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109: 4052.
  • 7
    Munakata J, Naliboff B, Harraf F, et al. Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology 1997; 112: 5563.
  • 8
    Bouin M, Plourde V, Boivin M, et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002; 122: 17717.
  • 9
    Kendall GP, Thompson DG, Day SJ, et al. Inter- and intraindividual variation in pressure–volume relations of the rectum in normal subjects and patients with the irritable bowel syndrome. Gut 1990; 31: 10628.
  • 10
    Camilleri M, Coulie B, Tack JF. Visceral hypersensitivity: facts, speculations, and challenges. Gut 2001; 48: 12531.
  • 11
    Naliboff BD, Munakata J, Fullerton S, et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut 1997; 41: 50512.
  • 12
    Stanghellini V, De Ponti F, De Giorgio R, et al. New developments in the treatment of functional dyspepsia. Drugs 2003; 63: 86992.
  • 13
    Tack J, Caenepeel P, Fischler B, et al. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121: 52635.
  • 14
    Svedlund J, Sjodin I, Dotefall G. GSRS – a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33: 12934.
  • 15
    Kuiken SD, Tytgat GN, Boeckxstaens GE. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo controlled study. Clin Gastroenterol Hepatol 2003; 1: 21928.
  • 16
    Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 2936.
  • 17
    Metz CE. ROC methodology in radiologic imaging. Invest Radiol 1986; 21: 72033.
  • 18
    Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 83943.
  • 19
    Steens J, Van Der Schaar PJ, Penning C, et al. Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome. Neurogastroenterol Motil 2002; 14: 2417.
  • 20
    Harraf F, Schmulson M, Saba L, et al. Subtypes of constipation predominant irritable bowel syndrome based on rectal perception. Gut 1998; 43: 38894.
  • 21
    Oettle GJ, Heaton KW. ‘Rectal dissatisfaction’ in the irritable bowel syndrome. A manometric and radiological study. Int J Colorectal Dis 1986; 1: 1835.
  • 22
    Lembo T, Naliboff B, Munakata J, et al. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol 1999; 94: 13206.
    Direct Link:
  • 23
    Camilleri M, Chey WY, Mayer EA, et al. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med 2001; 161: 173340.
  • 24
    Novick J, Miner P, Krause R, et al. A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2002; 16: 187788.